-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cluster headache (CH) is a primary headache disease characterized by strong unilateral orbital, supraorbital, and/or temporal pain, lasting 15-180 minutes, and accompanied by symptoms of autonomic nerves on the same side and / Or irritability
.
Most patients have paroxysmal CH.
Current treatment strategies include suspension of acute episodes, aims to prevent reduction in seizure frequency of treatment
Blood vessel
They found that four independent locus (loci) (r2<0.
1) are associated with cluster headache and have genome-wide significance (p<5×10-8), rs11579212 (OR=1.
51), rs6541998 (OR=1.
53) , Rs10184573 (OR = 1.
43) and rs2499799 (OR = 0.
62, 95% CI 0.
54-0.
73, close to UFL1/FHL5), together explain 7.
2% of the phenotypic variation
The important significance of this research is that the genetic risk site of cluster headache was discovered and replicated through GWAS , and its effect size is larger than that usually seen in complex genetic diseases
.
.
Through GWAS , the genetic risk locus of cluster headache was discovered and replicated, and its effect size is larger than that usually seen in complex genetic diseases
Leave a message here